| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 10/25/2001 | WO2001078683A2 Sustained release formulations comprising growth hormone |
| 10/25/2001 | WO2001078682A2 Sustained release drug compositions |
| 10/25/2001 | WO2001078681A1 Drug delivery system for avoiding pharmacokinetic interaction between drugs and method thereof |
| 10/25/2001 | WO2001078680A2 Pharmaceutical compositions comprising fluvastatin |
| 10/25/2001 | WO2001078678A1 Pre-formed sheet devices suitable for topical application |
| 10/25/2001 | WO2001078675A1 Use of natural substances in the production of cosmetic preparations |
| 10/25/2001 | WO2001078662A1 Hair growth stimulant compositions with sustained action |
| 10/25/2001 | WO2001078660A2 Topical micronutrient delivery system and uses thereof |
| 10/25/2001 | WO2001078626A1 Targeted therapeutic agent release devices and methods of making and using the same |
| 10/25/2001 | WO2001027099A3 Bicyclic compounds composition and method for stabilizing the same |
| 10/25/2001 | WO2001022993A3 MUCOSAL DTPa VACCINES |
| 10/25/2001 | WO2001021154A3 Surface modified particulate compositions of biologically active substances |
| 10/25/2001 | US20010034432 Surrounds an elloptiod ro spehrical shape which contains an attractant such as streptavidin or avidin and is anchored to to the protein; isolation and purification while maintaining in a wild-type conformation |
| 10/25/2001 | US20010034374 Core formulation |
| 10/25/2001 | US20010034367 Compositions and methods for the treatment of cystic fibrosis |
| 10/25/2001 | US20010034358 Human immunodeficiency syndrone, hepatitis virus |
| 10/25/2001 | US20010034354 Antiulcer agents |
| 10/25/2001 | US20010034349 Methods of hydrating mucosal surfaces |
| 10/25/2001 | US20010034339 For eyes, ears or noses |
| 10/25/2001 | US20010034333 Cyclodextrin polymer compositions for use as drug carriers |
| 10/25/2001 | US20010033888 Controlling supersaturation, elongated crystal structure, can be easily separated and dried |
| 10/25/2001 | US20010033870 A combination of an estrogen and progestin for female hormoe replacement therapy, to provide contraception; minimizes skin damage, irritation or sensitization |
| 10/25/2001 | US20010033868 Biodegradable polymer |
| 10/25/2001 | US20010033867 Systems and methods for local delivery of an agent |
| 10/25/2001 | US20010033866 Sustained release oral formulations |
| 10/25/2001 | US20010033865 Melt-extrusion multiparticulates |
| 10/25/2001 | US20010033864 Low dose entecavir formulation and use |
| 10/25/2001 | US20010033863 Using robots |
| 10/25/2001 | US20010033861 Liposomes containing an entrapped compound in supersaturated solution |
| 10/25/2001 | US20010033860 Mixture with lipid carrier |
| 10/25/2001 | US20010033859 Transdermal therapeutic system for delivery of dofetilide |
| 10/25/2001 | US20010033858 Sustained release |
| 10/25/2001 | US20010033848 Adjustment of cellular nicotinamide-adenine dinucleotide |
| 10/25/2001 | US20010033845 Therapeutic composition comprising an antigen or an in vivo generator of a compound comprising an amino acid sequence |
| 10/25/2001 | US20010033838 Animal derived lipid |
| 10/25/2001 | US20010033831 Containing calcium phosphate; remineralization of teeth |
| 10/25/2001 | US20010033830 Porous particles for deep lung delivery |
| 10/25/2001 | US20010033829 Biodegradable material |
| 10/25/2001 | US20010033828 Porous particles for deep lung delivery |
| 10/25/2001 | US20010033827 Inhibition of mucin release from airway goblet cells by polycationic peptides |
| 10/25/2001 | US20010032643 Closure-cap and container as a two-chamber cartridge for nebulisers for producing aerosols and active substance formulations, suitable for storage |
| 10/25/2001 | DE10105759C1 Electrically and magnetically assisted charge carrier delivery device e.g. for transdermal application of pharmaceuticals, has electrical and magnetic fields applied to charge carrier reservoir layer |
| 10/25/2001 | DE10018834A1 Transdermal or transmucosal pharmaceutical dosage form for treatment of nicotine dependence or smoking withdrawal contains nicotine compound or substitute and CNS active compound |
| 10/25/2001 | DE10018783A1 Stable aqueous ciprofloxacin infusion solutions containing sulfuric acid as the stabilizing agent useful for the treatment of bacterial infections in humans and animals |
| 10/25/2001 | DE10018781A1 Aqueous ciprofloxacin infusion solutions containing orthophosphoric acid monoester or diester as solubilizing and stabilizing agent useful for the treatment of bacterial infections |
| 10/25/2001 | CA2407065A1 A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component |
| 10/25/2001 | CA2407063A1 Solid dispersion with improved absorbability |
| 10/25/2001 | CA2406403A1 Tissue-specific and pathogen-specific toxic agents, ribozymes, dnazymes and antisense oligonucleotides, and methods of use thereof |
| 10/25/2001 | CA2406226A1 Rapid-onset formulation of a selective cyclooxigenase-2 |
| 10/25/2001 | CA2405659A1 Particulate composition |
| 10/25/2001 | CA2405599A1 Medicaments for treating respiratory disorders comprising formoterol and fluticasone |
| 10/25/2001 | CA2405385A1 Hair growth stimulant compositions with sustained action |
| 10/25/2001 | CA2403591A1 Pharmaceutical compositions comprising fluvastatin |
| 10/25/2001 | CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 10/24/2001 | EP1148106A1 Pressure-sensitive adhesive composition and moisture-permeable pressure-sensitive adhesive tape, pressure-sensitive adhesive drug composition, and pressure-sensitive adhesive tape preparation each containing the composition |
| 10/24/2001 | EP1147781A1 Biodegradable implant precursor |
| 10/24/2001 | EP1147778A1 Stable gel formulation for topical treatment of skin conditions |
| 10/24/2001 | EP1147777A1 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors |
| 10/24/2001 | EP1147770A1 Virginiamycin mixture |
| 10/24/2001 | EP1147768A1 Transdermal therapeutic system for administering dofetilide |
| 10/24/2001 | EP1147767A1 Controlled release formulations of nimesulide and a process for the manufacture thereof |
| 10/24/2001 | EP1147766A2 Pharmaceutical compositions |
| 10/24/2001 | EP1147223A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 10/24/2001 | EP1147175A2 Fibres for culturing eukaryotic cells |
| 10/24/2001 | EP1147167A1 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof |
| 10/24/2001 | EP1147148A1 Dextran-maleic acid monoesters and hydrogels based thereon |
| 10/24/2001 | EP1146964A1 Milling process for the production of finely milled medicinal substances |
| 10/24/2001 | EP1146959A1 Method and apparatus for liposome production |
| 10/24/2001 | EP1146956A1 Microemulsions containing water and hydrofluoroethers |
| 10/24/2001 | EP1146908A1 Formulations comprising antisense nucleotides to connexins |
| 10/24/2001 | EP1146907A2 Use of cationic lipids to generate anti-tumor immunity |
| 10/24/2001 | EP1146906A1 Mucosal delivery system |
| 10/24/2001 | EP1146900A2 Dna vaccines against hantavirus infections |
| 10/24/2001 | EP1146896A2 Monodisperse hexameric acylated insulin analog formulations |
| 10/24/2001 | EP1146895A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions |
| 10/24/2001 | EP1146890A2 Buccal delivery system for proteinaceous medicaments |
| 10/24/2001 | EP1146876A2 Compositions having improved stability |
| 10/24/2001 | EP1146865A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol |
| 10/24/2001 | EP1146864A1 Ph independent extended release pharmaceutical formulation |
| 10/24/2001 | EP1146863A1 Lyophilisates with improved reconstitutibility |
| 10/24/2001 | EP1146862A1 Pharmaceutical compositions |
| 10/24/2001 | EP1146861A1 Hydrogel particle formulations |
| 10/24/2001 | EP1146860A2 Polymeric delivery agents and delivery agent compounds |
| 10/24/2001 | EP1146859A1 Method of preparing particles for agglomeration |
| 10/24/2001 | EP1146858A1 Non-invasive vaccination through the skin |
| 10/24/2001 | EP1146857A2 Materials and methods for making improved micelle compositions |
| 10/24/2001 | EP1146856A1 Spheronised self-emulsifying system for hydrophobic and water-sensitive agents |
| 10/24/2001 | EP1146855A1 Therapeutic delivery using compounds self-assembled into high axial ratio microstructures |
| 10/24/2001 | EP1146852A1 A cosmetic composition based on menthol and menthyl lactate, having little odor and being non-irritating |
| 10/24/2001 | EP1146851A1 Galenic formulation containing biotin |
| 10/24/2001 | EP1146845A2 Compressed lecithin preparations |
| 10/24/2001 | EP1146792A1 Chewing gum with dental health benefits employing calcium lactate |
| 10/24/2001 | EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer |
| 10/24/2001 | EP0934593A4 Electrically conductive adhesive hydrogels |
| 10/24/2001 | EP0904064B1 Oral pharmaceutical compositions containing sex hormones |
| 10/24/2001 | EP0863751B1 Improved method for preventing crystal formation in a dispersion of a liquid in a matrix |
| 10/24/2001 | EP0847242B1 Sugar-free dragee-like products |
| 10/24/2001 | EP0844868B1 Compositions including O-carboxymethyl chitosan and use in ophthalmics |
| 10/24/2001 | EP0828479B1 Method of producing a solid dispersion of a poorly water soluble drug |
| 10/24/2001 | EP0818994B1 Method of making a pressure sensitive skin adhesive sheet material |